Amgad M Moussa

Dr. Amgad M Moussa

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
AMAmgad M Moussa
Amgad M Moussa
JCJuan Camacho
Juan Camacho
MMMajid Maybody
Majid Maybody
AGAdrian J. Gonzalez-Aguirre
Adrian J. Gonzalez-Aguirre
FRFourat Ridouani
Fourat Ridouani
ESErnesto Santos
Ernesto Santos

27 April 2020 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
AMAmgad M Moussa
Amgad M Moussa
MMMajid Maybody
Majid Maybody
AGAdrian J. Gonzalez-Aguirre
Adrian J. Gonzalez-Aguirre
JBJessica L. Buicko
Jessica L. Buicko
ASAshok R. Shaha
Ashok R. Shaha
EMErnesto Santos Martin
Ernesto Santos Martin

2 January 2021 in Current Oncology Reports
Verified
Journal Article
Closed access
PDF file
AMAmgad M Moussa
Amgad M Moussa
EZEtay Ziv
Etay Ziv

31 May 2022 in Current Oncology Reports
Verified
Journal Article
Closed access
PDF file
EYEslam Wassal Youssef
Eslam Wassal Youssef
AAAhmed Aly
Ahmed Aly
ABAkshaar Brahmbhatt
Akshaar Brahmbhatt
AMAmgad M Moussa
Amgad M Moussa
EMErnesto Santos Martin
Ernesto Santos Martin

1 May 2023 in Diagnostic and Interventional Radiology
Verified
Journal Article
Open access
AMAmgad M Moussa
Amgad M Moussa
AAAhmed K. Aly
Ahmed K. Aly
MMMajid Maybody
Majid Maybody
JCJuan Camacho
Juan Camacho
FRFourat Ridouani
Fourat Ridouani
EMErnesto Santos Martin
Ernesto Santos Martin
To compare the safety and efficacy of sclerotherapy and lymphatic embolization (LE) in the treatment of symptomatic iatrogenic lymphoceles following the placement of a percutaneous drainage catheter. This is a retrospective study of 46 patients who underwent sclerotherapy (17 patients) or LE (29 patients) for the management of symptomatic iatrogenic lymphoceles following percutaneous drain placement between January 2017 and December 2021. The demographic characteristics, time between surgery and lymphatic intervention, clinical presentation, number of procedures, drain output pre- and post-intervention, time from intervention to drain removal, and adverse events were collected and compared for both groups. The clinical success rate, defined as the successful removal of the drain after one procedure, was calculated. Adverse events were reported according to the Society of Interventional Radiology classification. A statistical analysis was conducted using SPSS, and the P value for statistical significance was set at 0.05. The Mann-Whitney U test was used to compare differences in the scale variables, and Fisher's exact test was used to compare the categorical and ordinal variables between both groups. A total of 46 patients with 49 lymphoceles met the inclusion criteria of the study. Of these patients, 17 patients (19 lymphoceles) underwent sclerotherapy, and 29 patients (30 lymphoceles) underwent LE as their initial procedures. The clinical success after one procedure was significantly higher (83% vs. 47%, P = 0.011), and the median time between the first intervention and drain removal was significantly shorter in the LE group (median duration of 6 vs. 13 days, P = 0.018) compared with the sclerotherapy group. No statistically significant difference in adverse events was noted between both groups (0.26 vs. 0.10, P = 0.11). This study found that LE had a higher clinical success rate after the first procedure and a shorter time to drain removal compared with sclerotherapy. There was no difference in the rate of adverse events between both groups. Although LE is a safe and promising technique, a prospective study is needed to further compare the efficacy of both treatment modalities.

17 October 2022 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
AAAhmed K. Aly
Ahmed K. Aly
HYHooman Yarmohammadi
Hooman Yarmohammadi
RBRaazi Bajwa
Raazi Bajwa
MSMikhail Silk
Mikhail Silk
MHMeier Hsu
Meier Hsu
AMAmgad M Moussa
Amgad M Moussa